Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes
Erica P. Cai, Yuki Ishikawa, Wei Zhang, Nayara C. Leite, Jian Li, Shurong Hou, Badr Kiaf, Jennifer Hollister‐Lock, Neşe Kurt Yılmaz, Celia A. Schiffer, Douglas A. Melton, Stephan Kissler, Yi Peng
Topics & Concepts
Beta cellInduced pluripotent stem cellType 1 diabetesBETA (programming language)BiologyCRISPRImmunologyAutoimmunityDiabetes mellitusGenome editingCancer researchCell biologyGeneGeneticsEmbryonic stem cellEndocrinologyImmune systemIsletProgramming languageComputer sciencePancreatic function and diabetesEndoplasmic Reticulum Stress and DiseaseAdenosine and Purinergic Signaling